Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,630
Total Claims
$3.1M
Drug Cost
582
Beneficiaries
$5,346
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-55%
Opioid rate vs peers
1.2% vs 2.6% avg
+401%
Cost per patient vs peers
$5,346 vs $1,068 avg
+131%
Brand preference vs peers
20.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.2%
Opioid Rate
240
Opioid Claims
$4,656
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,917 claims · $2.6M
Generic: 14,960 claims · $385K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 439 | $438K |
| Dulaglutide | 352 | $398K |
| Semaglutide | 329 | $371K |
| Apixaban | 217 | $154K |
| Linaclotide | 156 | $105K |
| Sitagliptin Phosphate | 135 | $96K |
| Empagliflozin/Metformin Hcl | 124 | $83K |
| Budesonide/Formoterol Fumarate | 191 | $75K |
| Insulin Aspart | 71 | $60K |
| Dapagliflozin Propanediol | 58 | $54K |
| Sitagliptin Phos/Metformin Hcl | 56 | $52K |
| Tiotropium Bromide | 80 | $52K |
| Linagliptin | 54 | $50K |
| Fluticasone/Umeclidin/Vilanter | 47 | $38K |
| Denosumab | 22 | $37K |
Prescribing Profile
Patient Profile
71
Avg Age
57%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About